Mergers & Acquisitions - Mallinckrodt

Filter

Current filters:

Mallinckrodt

Popular Filters

Mallinckrodt to buy Cadence Pharma for around $1.3 billion

12-02-2014

Ireland-headquartered specialty drugmaker Mallinckrodt, spun off by Covidien last year, has entered into…

Cadence PharmaceuticalsMallinckrodtMergers & AcquisitionsOfirmevPharmaceutical

Covidien to spin out pharma business to Mallinckrodt

27-05-2013

Ireland-based health care products group Covidien (NYSE: COV) says that its board of directors has approved…

CovidienMallinckrodtMergers & AcquisitionsPharmaceutical

Covidien files Form 10 registration statement for planned spin-off of Pharma business

04-02-2013

Ireland-based medical products and generic drugmaker Covidien (NYSE: COV) has announced the initial filing…

CovidienMallinckrodtMergers & AcquisitionsPharmaceutical

Mallinckrodt to acquire CNS Thera for $100 million; Mediq to sell out for 775 million euros

25-09-2012

Mallinckrodt, the soon to be spun-out pharmaceuticals business of Ireland-based Covidien (NYSE: COV),…

CNS TherapeuticsCovidienGenericsMallinckrodtMediqMergers & AcquisitionsPharmaceutical

Back to top